The Limited Times

Now you can see non-English news...

Trump undergoes a controversial corona treatment - funds are actually only used in severe cases

2020-10-03T20:53:54.294Z


US President Donald Trump has been infected with the corona virus, now the 74-year-old is being treated with a daring drug cocktail. Experts criticize the treatment in the strongest possible terms.


US President Donald Trump has been infected with the corona virus, now the 74-year-old is being treated with a daring drug cocktail.

Experts criticize the treatment in the strongest possible terms.

  • Donald Trump and First Lady Melania have contracted the corona virus.

  • The US president was admitted to a clinic on Friday.

  • The way it is treated is sharply criticized by some experts.

Washington - Donald Trump's corona infection caused a stir late on

Thursday evening

(local time), in the middle of the US election campaign * the

US President

was surprisingly admitted to a hospital.

Although the 74-year-old has only had mild

symptoms *

according to official information

, Trump is now being treated with an experimental drug.

A decision that

experts

criticize.

Meanwhile, the election campaign for challenger Joe Biden continues.

Biden was also previously tested for the corona virus *, now the result is there.

But an event in the White House apparently turned into a superspreader event, and the number of infections continues to rise.

Donald Trump falls ill with corona: US President is treated in clinic

The drug is a non-approved

drug *

that

is still in the trial phase.

"We shouldn't give the president this drug until it's proven effective," wrote

emergency physician

Jeremy Faust of Brigham and Women's Hospital in Boston on

Twitter

on Friday

.

Medical professor

Vinay Prasad from the

University of California in San Francisco also

criticized the decision severely: "It is bad science, bad medicine * and bad ethics to give powerful people untried things that are not given to normal people".

US President Donald Trump infected with corona - experts criticize drug cocktail

Trump's personal physician Sean Conley

had previously announced that the US president had been treated with an experimental antibody cocktail before he was transferred to the hospital.

As a "precautionary measure", the 74-year-old received a dose of synthetic antibodies from the US pharmaceutical company Regeneron.

The treatment with the

antibody cocktail

is currently being

investigated

in clinical

studies

; the agent is not approved.

Regeneron boss Leonard Schleifer

told the "New York Times" that his company was

"happy to comply" with

the

White House's

request

for the agent.

Trump is not the first patient to receive the drug on the basis of an exception.

Just a few days ago, the

US company announced

that initial tests had achieved initial success.

Accordingly, it has been shown that the intravenously administered antibody cocktail can

reduce

the

viral load

in

corona patients

who

are

not

treated

in the

hospital

and can shorten the recovery time.

Donald Trump: US President gets corona antibody cocktail - and another drug

But the

antibody cocktail

,

which has not yet been approved,

is not the only drug that the US president was given.

As

Donald Trump's

personal

physician

confirmed on Friday, the 74-year-old will be treated in parallel with the drug Remdesivir.

The US president is doing “very well” and does not need any

oxygen supply

.

He took a first dose of Remdesivir and has been resting since then.

Doctors see

Remdesivir,

which was originally developed to treat

Ebola

, not as a panacea for


Covid-19 disease, but often as helpful.

According to the manufacturer, the drug can

significantly reduce

the

risk of death

in the event of a severe course of the

corona disease Covid-19 *

.

The drug is usually not used for mild progressions.

Officially, US President Donald Trump has only had mild symptoms so far.

Source: merkur

All news articles on 2020-10-03

Similar news:

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.